| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.19M | 99.34M | 102.97M | 129.66M | 104.92M | 78.77M |
| Gross Profit | 23.72M | 63.93M | 65.58M | 28.03M | 23.72M | 15.09M |
| EBITDA | 1.86M | -1.57M | -22.00K | 6.56M | 7.30M | 6.70M |
| Net Income | -2.74M | -5.27M | -4.00M | 516.00K | 1.36M | 1.57M |
Balance Sheet | ||||||
| Total Assets | 74.84M | 77.08M | 85.95M | 98.47M | 92.60M | 81.05M |
| Cash, Cash Equivalents and Short-Term Investments | 11.54M | 10.61M | 9.21M | 8.11M | 7.75M | 7.27M |
| Total Debt | 21.83M | 23.50M | 24.75M | 24.27M | 20.04M | 14.27M |
| Total Liabilities | 50.60M | 56.67M | 60.38M | 66.40M | 58.09M | 51.15M |
| Stockholders Equity | 24.23M | 20.41M | 25.57M | 32.06M | 34.51M | 29.90M |
Cash Flow | ||||||
| Free Cash Flow | 4.76M | 5.64M | 2.98M | -1.70M | -3.14M | 4.46M |
| Operating Cash Flow | 6.24M | 7.65M | 7.17M | 4.69M | 3.06M | 7.59M |
| Investing Cash Flow | -2.98M | -3.25M | -4.32M | -6.64M | -6.60M | -4.49M |
| Financing Cash Flow | -2.54M | -2.80M | -1.48M | 1.48M | 4.41M | -4.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £174.66M | 8.69 | 18.25% | 2.00% | 15.56% | -92.94% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | £25.03M | 3.80 | -12.28% | ― | 4.99% | 56.79% | |
58 Neutral | £866.19M | -28.06 | -6.85% | 1.34% | -11.78% | -92.61% | |
56 Neutral | £148.93M | -34.00 | 3.39% | ― | 1.45% | ― | |
55 Neutral | £3.73B | 28.33 | 1.69% | 6.76% | 3.30% | -58.67% | |
46 Neutral | £257.58M | 131.42 | 0.79% | 2.44% | -4.71% | 86.21% |